Back to today’s briefing

Story perspectives

AstraZeneca Soars Amid FTSE Rally and Rate Cut Hopes

11/12/2025

35 5

Summary

Story summary

AstraZeneca PLC rose on November 11, 2025, surpassing its September 2024 peak and becoming the largest UK-listed stock.
The shares rose 2.5% to 134.6 pounds, aiding a broader FTSE 100 rally that hit new highs.
The surge followed strong quarterly earnings and a U.S. drug-pricing deal that eased policy uncertainty.
UK unemployment rose to 5%, the highest in four years, increasing expectations for a Bank of England rate cut in December.

1 of 1

Story summary

AstraZeneca PLC rose on November 11, 2025, surpassing its September 2024 peak and becoming the largest UK-listed stock.
The shares rose 2.5% to 134.6 pounds, aiding a broader FTSE 100 rally that hit new highs.
The surge followed strong quarterly earnings and a U.S. drug-pricing deal that eased policy uncertainty.
UK unemployment rose to 5%, the highest in four years, increasing expectations for a Bank of England rate cut in December.